Search Orphan Drug Designations and Approvals
-
Generic Name: | Aldesleukin |
---|---|
Date Designated: | 11/24/1998 |
Orphan Designation: | For the treatment non-Hodgkin's lymphoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Iovance Biotherapeutics, Inc. 825 Industrial Road, Suite 400 San Carlos, California 94070 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-